These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 23415776

  • 1. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
    Sharma N, Goel M, Bansal S, Agarwal P, Titiyal JS, Upadhyaya AD, Vajpayee RB.
    Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
    Hyndiuk RA, Eiferman RA, Caldwell DR, Rosenwasser GO, Santos CI, Katz HR, Badrinath SS, Reddy MK, Adenis JP, Klauss V.
    Ophthalmology; 1996 Nov; 103(11):1854-62; discussion 1862-3. PubMed ID: 8942881
    [Abstract] [Full Text] [Related]

  • 8. Moxifloxacin for bacterial keratitis.
    Rosenberg J, Eisen L, Kim J.
    Ophthalmology; 2008 Jun; 115(6):1103; author reply 1103. PubMed ID: 18519075
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis.
    Khokhar S, Sindhu N, Mirdha BR.
    Infection; 2000 Jun; 28(3):149-52. PubMed ID: 10879638
    [Abstract] [Full Text] [Related]

  • 10. Monotherapy versus fortified antibiotics for bacterial keratitis.
    Rosenberg JB, Gritz DC.
    Cornea; 2011 Sep; 30(9):1066; author reply 1066-7. PubMed ID: 21775886
    [No Abstract] [Full Text] [Related]

  • 11. Fourth-generation fluoroquinolone-resistant bacterial keratitis.
    Jhanji V, Sharma N, Satpathy G, Titiyal J.
    J Cataract Refract Surg; 2007 Aug; 33(8):1488-9. PubMed ID: 17662450
    [Abstract] [Full Text] [Related]

  • 12. Fluoroquinolones in corneal ulcers.
    Galvis V, Tello A, Guerra AR, Acuña MF, Villarreal D.
    Ophthalmology; 2013 Sep; 120(9):e61-2. PubMed ID: 24001539
    [No Abstract] [Full Text] [Related]

  • 13. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).
    Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR, Steroids for Corneal Ulcers Trial Group.
    Arch Ophthalmol; 2012 Feb; 130(2):143-50. PubMed ID: 21987582
    [Abstract] [Full Text] [Related]

  • 14. The steroids for corneal ulcers trial: study design and baseline characteristics.
    Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR, Steroids for Corneal Ulcers Trial Group.
    Arch Ophthalmol; 2012 Feb; 130(2):151-7. PubMed ID: 21987581
    [Abstract] [Full Text] [Related]

  • 15. The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.
    Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, O'Brien KS, Glidden DV, Ray KJ, Oldenburg CE, Zegans ME, Whitcher JP, McLeod SD, Porco TC, Lietman TM, Acharya NR, Steroids for Corneal Ulcers Trial Group.
    Am J Ophthalmol; 2014 Feb; 157(2):327-333.e3. PubMed ID: 24315294
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.
    McDonald MB, Protzko EE, Brunner LS, Morris TW, Haas W, Paterno MR, Comstock TL, Usner DW.
    Ophthalmology; 2009 Sep; 116(9):1615-1623.e1. PubMed ID: 19643483
    [Abstract] [Full Text] [Related]

  • 17. Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.
    Bashir H, Dave A, Mathur U.
    Cornea; 2016 Aug; 35(8):e22-3. PubMed ID: 27227400
    [No Abstract] [Full Text] [Related]

  • 18. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.
    Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Ravindran M, Oldenburg CE, Ray KJ, Glidden D, Zegans ME, McLeod SD, Lietman TM, Acharya NR.
    Invest Ophthalmol Vis Sci; 2012 Jan 25; 53(1):267-72. PubMed ID: 22159005
    [Abstract] [Full Text] [Related]

  • 19. Nocardia keratitis: clinical course and effect of corticosteroids.
    Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Priya JL, Sy A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Lietman TM, Acharya NR.
    Am J Ophthalmol; 2012 Dec 25; 154(6):934-939.e1. PubMed ID: 22959881
    [Abstract] [Full Text] [Related]

  • 20. Author reply: To PMID 23415776.
    Sharma N, Goel M, Bansal S, Agarwal P, Titiyal J, Upadhyaya A, Vajpayee R.
    Ophthalmology; 2013 Sep 25; 120(9):e62. PubMed ID: 24001541
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.